ILLUMUS Update on COVID-19

UPDATED August 9, 2021

ILLUMUS is closely monitoring the Coronavirus (COVID-19) Pandemic, reviewing enterprise risk on a continuous basis and maintaining a constantly evolving business continuity strategy to minimize the threat of disruptions to our business.  As part of ILLUMUS’s planning and response to COVID-19, we want to notify you that as of today all factory visits require a signed consent form to be provided at the time of your visit. We have also enacted additional safety measures including mask requirements and social distancing regardless of vaccination status.

Our business is still processing, manufacturing and shipping orders without interruption.  We have large amounts of stock on hand for both of our brands and our sales team is available to assist you on all your needs.

In the meantime, we’ll continue to actively monitor guidance and data from both the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC), providing updates regarding any changes to our business process and capabilities.